CLINICAL RESEARCH: BIOMARKERS
Adipokines, Insulin Resistance, and Coronary Artery Calcification
Atif Qasim, MD*,
Nehal N. Mehta, MD*,
Mahlet G. Tadesse, ScD ,
Megan L. Wolfe, BS*,
Thomas Rhodes, MSPH ,
Cynthia Girman, DrPH and
Muredach P. Reilly, MB*,*
* Cardiovascular Institute and Institute for Translational Medicine and Therapeutics, Department of Medicine, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania
Department of Mathematics, Georgetown University, Washington, DC
Department of Epidemiology, Merck Research Laboratories, West Point, Pennsylvania.
Manuscript received January 29, 2008;
revised manuscript received April 25, 2008,
accepted April 28, 2008.
* Reprint requests and correspondence: Dr. Muredach P. Reilly, Cardiovascular Institute, University of Pennsylvania Medical Center, 909 BRB 2/3, 421 Curie Boulevard, Philadelphia, Pennsylvania. (Email: muredach{at}spirit.gcrc.upenn.edu).
Objectives: We evaluated the hypothesis that plasma levels of adiponectin and leptin are independently but oppositely associated with coronary artery calcification (CAC), a measure of subclinical atherosclerosis. In addition, we assessed which biomarkers of adiposity and insulin resistance are the strongest predictors of CAC beyond traditional risk factors, metabolic syndrome, and plasma C-reactive protein (CRP).
Background: Adipokines are fat-secreted biomolecules with pleiotropic actions that converge in diabetes and cardiovascular disease.
Methods: We examined the association of plasma adipocytokines with CAC in 860 asymptomatic, nondiabetic participants in the SIRCA (Study of Inherited Risk of Coronary Atherosclerosis).
Results: Plasma adiponectin and leptin levels had opposite and distinct associations with adiposity, insulin resistance, and inflammation. Plasma leptin was positively (top vs. bottom quartile) associated with higher CAC after adjustment for age, gender, traditional risk factors, and Framingham risk scores (tobit regression ratio 2.42 (95% confidence interval [CI]: 1.48 to 3.95; p = 0.002) and further adjustment for metabolic syndrome and CRP (tobit regression ratio: 2.31; 95% CI: 1.36 to 3.94; p = 0.002). In contrast, adiponectin levels were not associated with CAC. Comparative analyses suggested that levels of leptin, interleukin-6, and soluble tumor necrosis factor receptor-2, as well as the homeostasis model assessment of insulin resistance (HOMA-IR) index, predicted CAC scores, but only leptin and HOMA-IR provided value beyond risk factors, metabolic syndrome, and CRP.
Conclusions: In SIRCA, although both leptin and adiponectin levels were associated with metabolic and inflammatory markers, only leptin was a significant independent predictor of CAC. Of several metabolic markers, leptin and the HOMA-IR index had the most robust, independent associations with CAC.
Key Words: adiponectin leptin coronary artery calcification atherosclerosis inflammation
|
Abbreviations and Acronyms
| | BMI = body mass index | | CAC = coronary artery calcium | | CAD = coronary artery disease | | CRP = C-reactive protein | | CVD = cardiovascular disease | | FRS = Framingham risk score | | HOMA-IR = homeostasis model assessment of insulin resistance | | IL = interleukin | | IMT = intima-media thickness | | LRT = likelihood-ratio test | | sol-TNFR2 = soluble tumor necrosis factor receptor-2 |
|
This article has been cited by other articles:

|
 |

|
 |
 
S. S. Martin, A. Qasim, and M. P. Reilly
Leptin Resistance: A Possible Interface of Inflammation and Metabolism in Obesity-Related Cardiovascular Disease
J. Am. Coll. Cardiol.,
October 7, 2008;
52(15):
1201 - 1210.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|